Research ArticleCell Biology

Tumor Suppression by PTEN Requires the Activation of the PKR-eIF2α Phosphorylation Pathway

Science Signaling  22 Dec 2009:
Vol. 2, Issue 102, pp. ra85
DOI: 10.1126/scisignal.2000389

You are currently viewing the abstract.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Abstract

Inhibition of protein synthesis by phosphorylation of the α subunit of eukaryotic translation initiation factor 2 (eIF2) at Ser51 occurs as a result of the activation of a family of kinases in response to various forms of stress. Although some consequences of eIF2α phosphorylation are cytoprotective, phosphorylation of eIF2α by RNA-dependent protein kinase (PKR) is largely proapoptotic and tumor suppressing. Phosphatase and tensin homolog deleted from chromosome 10 (PTEN) is a tumor suppressor protein that is mutated or deleted in various human cancers, with functions that are mediated through phosphatase-dependent and -independent pathways. Here, we demonstrate that the eIF2α phosphorylation pathway is downstream of PTEN. Inactivation of PTEN in human melanoma cells reduced eIF2α phosphorylation, whereas reconstitution of PTEN-null human glioblastoma or prostate cancer cells with either wild-type PTEN or phosphatase-defective mutants of PTEN induced PKR activity and eIF2α phosphorylation. The antiproliferative and proapoptotic effects of PTEN were compromised in mouse embryonic fibroblasts that lacked PKR or contained a phosphorylation-defective variant of eIF2α. Induction of the pathway leading to phosphorylation of eIF2α required an intact PDZ-binding motif in PTEN. These findings establish a link between tumor suppression by PTEN and inhibition of protein synthesis that is independent of PTEN’s effects on phosphoinositide 3′-kinase signaling.

View Full Text